☆ 4.5 Review

Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Evaluation of favipiravir in the treatment of COVID-19 based on the real-world

Weishang Deng et al.

Summary: For mild-to-moderate COVID-19 patients, FVP significantly promotes viral clearance, reduces hospitalization duration, and helps lower the risk of severe disease outcomes. However, there is no significant benefit of FVP for severe patients, indicating caution is needed in treatment options.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)

添加到收藏夹

Article Virology

Efficacy and safety of current treatment interventions for patients with severe COVID-19 infection: A network meta-analysis of randomized controlled trials

Qinglin Cheng et al.

Summary: This study showed that methylprednisolone was more effective than placebo in treating patients with severe COVID-19 infection. It also suggested that convalescent plasma (CP) may be safer and more effective compared to other treatment interventions for severe COVID-19 patients.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Comparative Efficacy of Chinese Herbal Injections for Treating Severe Pneumonia: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials

Liqing Niu et al.

Summary: This study assessed the effectiveness of Chinese herbal injections (CHIs) in the treatment of severe pneumonia (SP) and ranked different treatment options using Bayesian network meta-analysis (NMA). The results showed that combining CHIs such as Xuebijing injection (XBJ), Tanreqing injection (TRQ), Reduning injection (RDN), and Shenmai injection (SM) with conventional Western medicine (WM) significantly improved the clinical effective rate compared to WM alone. Among them, TRQ + WM ranked the highest in terms of clinical effective rate.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Infectious Diseases

Integrative role of traditional and modern technologies to combat COVID-19

Mohammad Heiat et al.

Summary: Traditional and emerging approaches are both crucial for the prevention, diagnosis, and treatment of COVID-19. Traditional sciences are essential for preventive and supportive care of coronavirus infection, while modern technologies are beneficial in developing precise diagnosis and effective treatment methods. The integration of these sciences will enhance our efficiency in fighting the COVID-19 disease.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)

添加到收藏夹

Article Plant Sciences

Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification

Shanshan Jia et al.

Summary: RDNI, a patented Traditional Chinese medicine, can reduce lung damage, inhibit the overexpression of MAPKs, PKC, and p65 nuclear factor-κB, affect cytokine levels, reduce inflammation, and display antipyretic activity. Its underlying mechanisms may involve the modulation of cytokine levels and inflammation by regulating the expression of MAPKs, PKC, and p65 nuclear factor NF-κB.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

添加到收藏夹

Article Integrative & Complementary Medicine

The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial

Zhijian Luo et al.

Summary: The study demonstrates that Xuebijing injection can effectively suppress the cytokine storm in severe COVID-19 patients by reducing the secretion of pro-inflammatory cytokines IL-6, IL-8, and TNF-??????, increasing lymphocyte levels, and decreasing CRP levels. However, Xuebijing did not significantly reduce the 28-day mortality rate.

EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2021)

添加到收藏夹

Article Chemistry, Medicinal

Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial

Xin-Yi Zhang et al.

Summary: XYP injection showed promising results in reducing symptom duration and virus clearance time in patients with mild to moderate COVID-19, with lower risk of disease progression to severe stage. Further studies are needed to evaluate its efficacy in a larger cohort of COVID-19 patients.

PHYTOTHERAPY RESEARCH (2021)

添加到收藏夹

Review Medicine, General & Internal

Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019: a systematic review and network meta-analysis combining 66 trials

Shan-Shan Wu et al.

Summary: The study found that traditional Chinese medicine and corticosteroids may reduce mortality and increase the cure rate in COVID-19 patients, with no increased risk of adverse events; however, high-dose chloroquine may increase mortality, and other antiviral agents like interferons could increase the risk of adverse events. The current evidence is generally uncertain with low quality, highlighting the need for further high-quality trials.

CHINESE MEDICAL JOURNAL (2021)

添加到收藏夹

Article Plant Sciences

Re-Du-Ning injection ameliorates LPS-induced lung injury through inhibiting neutrophil extracellular traps formation

Chenxi Yang et al.

Summary: The study found that Re-Du-Ning injection (RDN) can alleviate LPS-induced acute lung injury (ALI) by inhibiting the MAPK pathway to reduce the formation of neutrophil extracellular traps (NETs).

PHYTOMEDICINE (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines

Ying Wu et al.

Summary: The study reviewed 14 Chinese patent medicines recommended by the Guidelines for diagnosis and management of COVID-19 (8th edition), finding that these medicines, when used in combination with conventional treatments, were effective in managing COVID-19 with few side effects.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Deciphering the potential anti-COVID-19 active ingredients in Andrographis paniculata (Burm. F.) Nees by combination of network pharmacology, molecular docking, and molecular dynamics

Rongfang Xie et al.

Summary: The study identifies potential drug candidates for COVID-19 in the herb Andrographis paniculata and explains the molecular mechanisms of Xiyanping Injection against COVID-19. Through molecular docking and dynamics simulations, it was found that certain compounds in A. paniculata have strong binding affinity to target active sites, providing insights into their therapeutic effects on COVID-19.

RSC ADVANCES (2021)

添加到收藏夹

Article Medicine, General & Internal

Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)

Pei-Fang Wei

CHINESE MEDICAL JOURNAL (2020)

添加到收藏夹

Review Biochemical Research Methods

Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review

Raheleh Torabi et al.

MOLECULAR AND CELLULAR PROBES (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Viral pneumonia in China: from surveillance to response

Lianhan Shang et al.

Lancet Public Health (2020)

添加到收藏夹

Review Medicine, General & Internal

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

Maximilian Huhn et al.

LANCET (2019)

添加到收藏夹

Article Social Sciences, Mathematical Methods

Visualizing assumptions and results in network meta-analysis: The network graphs package

Anna Chaimani et al.

STATA JOURNAL (2015)

添加到收藏夹

Article Integrative & Complementary Medicine

Integrated Chinese-western therapy versus western therapy alone on survival rate in patients with non-small-cell lung cancer at middle-late stage

Guoqiang Lin et al.

JOURNAL OF TRADITIONAL CHINESE MEDICINE (2013)

添加到收藏夹

Article Critical Care Medicine

The Eastern Association of the Surgery of Trauma approach to practice management guideline development using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology

Andrew J. Kerwin et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)

添加到收藏夹

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.